0 items USD 0.00Search
- Did you mean
- bruton’s tyrolit kinase
Your search for "Bruton's tyrosine kinase" gave back 21717 results.
The global Kinase Inhibitor Small Molecule Drugs market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR...
Catalog:
MRRPB5
July 2023
Price: USD 2,900.00
The global Kinase Inhibitor Small Molecule Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the...
Catalog:
GIR
July 2023
Price: USD 4,480.00
The global Kinase Inhibitor Small Molecule Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by...
Catalog:
GIR
July 2023
Price: USD 3,480.00
Kinase inhibitors for cancer therapy are a class of drugs that are used to inhibit the activity of abnormal kinases, thereby interfering with the...
Catalog:
GIR
April 2024
Price: USD 3,480.00
The global Generation III EGFR Inhibitors market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030...
Catalog:
GIR
March 2024
Price: USD 3,480.00
Sunitinib Malate is the orally bioavailable malate salt of an indolinone-based tyrosine kinase inhibitor with potential antineoplastic activity...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
TrkC Antibody, also known as Neurotrophic Tyrosine Kinase Receptor Type 3 antibody, is a specific antibody used to detect and study TrkC protein (...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Anti-VEGT Drugs market size was valued at US$ million in 2022. With growing demand in downstream market, the Anti-VEGT Drugs is forecast...
Catalog:
LPI
October 2023
Price: USD 3,660.00
Icotinib (trade name Conmana) is a highly selective, first generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). Icotinib...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Icotinib (trade name Conmana) is a highly selective, first generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). Icotinib...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Anticancer drugs are medications used to treat cancer by targeting and killing cancer cells or inhibiting their growth. The global Anticancer Drugs...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Vascular endothelial growth factor (VEGF) is an angiogenic factor responsible for the formation of blood vessels either from already existing blood...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The characterization of anaplastic lymphoma kinase (ALK) gene and their role in the development and progression of ALK positive cancer has...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Cancer Growth Inhibitor market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Generation III EGFR Inhibitors market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast...
Catalog:
GIR
March 2024
Price: USD 4,480.00
